Autoantibodies against a 43 kDa muscle protein in inclusion body myositis

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Salajegheh, Mohammad ^a,b,c   Lam, Theresa ^b   Greenberg, Steven A ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; MUSCLE PROTEIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INCLUSION BODY MYOSITIS; MALE; MOLECULAR WEIGHT; PROTEIN DEGRADATION; PROTEIN PROCESSING; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOSITIS, INCLUSION BODY; YOUNG ADULT;

EID: 79956350423     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020266     Document Type: Article

References (20)

1. Mammen AL, (2010) Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 1184: 134-153.
2. Dalakas MC, Illa I, Gallardo E, Juarez C, (1997) Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations. Ann Neurol 41: 100-104.
3. Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, et al. (2002) Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies. J Neurol 249: 69-75.
4. Engel AG, Arahata K, (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 16: 209-215.
5. Greenberg SA, (2001) DNA microarray gene expression analysis technology and its application to neurological disorders. Neurology 57: 755-761.
6. Greenberg SA, Sanoudou D, Haslett JN, Kohane IS, Kunkel LM, et al. (2002) Molecular profiles of inflammatory myopathies. Neurology 59: 1170-1182.
7. Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, et al. (2005) Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology 65: 1782-1787.
8. Bradshaw EM, Orihuela A, McArdel SL, Salajegheh M, Amato AA, et al. (2007) A Local Antigen-Driven Humoral Response Is Present in the Inflammatory Myopathies. J Immunol 178: 547-556.
9. Salajegheh M, Pinkus JL, Amato AA, Morehouse C, Jallal B, et al. (2010) Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve 42: 576-583.
10. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, et al. (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52: 1571-1576.
11. Greenberg SA, (2007) Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 69: 2008-2019.
12. Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, et al. (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49: 2370-2374.
13. Koffman BM, Rugiero M, Dalakas MC, (1998) Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21: 115-117.
14. Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, et al. (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60: 116-123.
15. Gunawardena H, Betteridge ZE, McHugh NJ, (2008) Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis. Curr Opin Rheumatol 20: 675-680.
16. Limaye VS, Lester S, Bardy P, Thompson P, Cox S, et al. (2010) A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis. Rheumatol Int.
17. Sordet C, Goetz J, Sibilia J, (2006) Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 73: 646-654.
18. Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, et al. (2009) RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum 60: 2193-2200.
19. Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, et al. (2010) Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 67: 53-63.
20. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, et al. (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14: 337-345.